Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 982

1.

Effects of lisinopril and nifedipine on the progression to overt albuminuria in IDDM patients with incipient nephropathy and normal blood pressure. The Italian Microalbuminuria Study Group in IDDM.

Crepaldi G, Carta Q, Deferrari G, Mangili R, Navalesi R, Santeusanio F, Spalluto A, Vanasia A, Villa GM, Nosadini R.

Diabetes Care. 1998 Jan;21(1):104-10.

PMID:
9538979
3.

Long-term comparison between perindopril and nifedipine in normotensive patients with type 1 diabetes and microalbuminuria.

Jerums G, Allen TJ, Campbell DJ, Cooper ME, Gilbert RE, Hammond JJ, Raffaele J, Tsalamandris C.

Am J Kidney Dis. 2001 May;37(5):890-9.

PMID:
11325669
4.
5.

Long-term renoprotection by perindopril or nifedipine in non-hypertensive patients with Type 2 diabetes and microalbuminuria.

Jerums G, Allen TJ, Campbell DJ, Cooper ME, Gilbert RE, Hammond JJ, O'Brien RC, Raffaele J, Tsalamandris C; Melbourne Diabetic Nephropathy Study Group.

Diabet Med. 2004 Nov;21(11):1192-9.

PMID:
15498085
6.

Course of renal function in type 2 diabetic patients with abnormalities of albumin excretion rate.

Nosadini R, Velussi M, Brocco E, Bruseghin M, Abaterusso C, Saller A, Dalla Vestra M, Carraro A, Bortoloso E, Sambataro M, Barzon I, Frigato F, Muollo B, Chiesura-Corona M, Pacini G, Baggio B, Piarulli F, Sfriso A, Fioretto P.

Diabetes. 2000 Mar;49(3):476-84.

PMID:
10868971
7.
9.

Long-term renoprotective effect of nisoldipine and lisinopril in type 1 diabetic patients with diabetic nephropathy.

Tarnow L, Rossing P, Jensen C, Hansen BV, Parving HH.

Diabetes Care. 2000 Dec;23(12):1725-30.

10.
11.

Glomerular hyperfiltration in the prediction of nephropathy in IDDM: a 10-year follow-up study.

Yip JW, Jones SL, Wiseman MJ, Hill C, Viberti G.

Diabetes. 1996 Dec;45(12):1729-33.

PMID:
8922358
13.

ACE inhibitor mediated reductions in renal size and microalbuminuria in normotensive, diabetic subjects.

Bakris GL, Slataper R, Vicknair N, Sadler R.

J Diabetes Complications. 1994 Jan-Mar;8(1):2-6.

PMID:
8167383
14.

Long-term lisinopril therapy reduces exercise-induced albuminuria in normoalbuminuric normotensive IDDM patients.

Tuominen JA, Ebeling P, Koivisto VA.

Diabetes Care. 1998 Aug;21(8):1345-8.

PMID:
9702445
15.

Early ACE-i intervention in microalbuminuric patients with type 1 diabetes: effects on albumin excretion, 24 h ambulatory blood pressure, and renal function.

Poulsen PL, Ebbehøj E, Nosadini R, Fioretto P, Deferrari G, Crepaldi G, Mogensen CE.

Diabetes Metab. 2001 Apr;27(2 Pt 1):123-8.

PMID:
11353877
16.
17.

Evidence of a threshold value of glycated hemoglobin to improve the course of renal function in type 2 diabetes with typical diabetic glomerulopathy.

Brocco E, Velussi M, Cernigoi AM, Abaterusso C, Bruseghin M, Carraro A, Sambataro M, Piarulli F, Sfriso A, Nosadini R.

J Nephrol. 2001 Nov-Dec;14(6):461-71.

PMID:
11783602
18.

Greater reduction of urinary albumin excretion in hypertensive type II diabetic patients with incipient nephropathy by lisinopril than by nifedipine.

Agardh CD, Garcia-Puig J, Charbonnel B, Angelkort B, Barnett AH.

J Hum Hypertens. 1996 Mar;10(3):185-92.

PMID:
8733038
20.

Systematic review on urine albumin testing for early detection of diabetic complications.

Newman DJ, Mattock MB, Dawnay AB, Kerry S, McGuire A, Yaqoob M, Hitman GA, Hawke C.

Health Technol Assess. 2005 Aug;9(30):iii-vi, xiii-163. Review.

Supplemental Content

Support Center